 Immix Biopharma IMMX stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration. The post IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today appeared first on InvestorPlace. 